Veru Inc. (VERU) Analysts See $-0.04 EPS

December 24, 2017 - By reb123z

 Veru Inc. (VERU) Analysts See $ 0.04 EPS

Analysts expect Veru Inc. (NASDAQ:VERU) to report $-0.04 EPS on December, 25.They anticipate $0.02 EPS change or 33.33 % from last quarter’s $-0.06 EPS. After having $-0.03 EPS previously, Veru Inc.’s analysts see 33.33 % EPS growth. The stock 0.14% or $0 during the last trading session, reaching $1.24. It is down 0.00% since December 24, 2016 and is . It has underperformed by 16.70% the S&P500.

Veru Inc., a medical therapeutics company, develops, makes, and markets consumer health care products. The company has market cap of $65.98 million. The companyÂ’s pharmaceuticals product portfolio includes Tamsulosin delayed release sachet that is under bioequivalence study for the treatment of benign prostatic hyperplasia; MSS-722, a fixed ratio of trans- and cis-clomiphene citrate isomers, which is under the Phase II clinical trial to treat male infertility caused by testicular dysfunction; APP-944, a zuclomiphene citrate that is under the Phase II clinical trial for the treatment of hot flashes in men on prostate cancer hormonal therapies; and APP-111, an oral tubulin targeting chemotherapy, which is under the preclinical study to treat metastatic prostate, breast, and ovarian cancers, as well as APP-111/112 oral agents that target colchicine binding site of tubulin for the treatment of gout and familial mediterranean fever. It currently has negative earnings. It also provides consumer health and medical devices, including PREBOOST benzocaine wipes for premature ejaculation; and FC2, which is female disposable contraceptive device, as well as FC2 Female Condom for unintended pregnancy and sexually transmitted infections, including HIV/AIDS and the Zika virus.

More notable recent Veru Inc. (NASDAQ:VERU) news were published by: Globenewswire.com which released: “Veru Inc. Reports Fiscal Third Quarter Financial Results” on August 08, 2017, also Streetinsider.com with their article: “Veru Inc. (VERU) Announces Acquisition of Novel Proprietary Formulation for …” published on December 11, 2017, Globenewswire.com published: “Veru Inc. to Present at Two Financial Conferences in September” on September 20, 2017. More interesting news about Veru Inc. (NASDAQ:VERU) were released by: Globenewswire.com and their article: “Veru Inc. Announces Change in Nasdaq Ticker Symbol to VERU” published on August 10, 2017 as well as Globenewswire.com‘s news article titled: “Veru Inc. to Participate in Upcoming Financial Conferences” with publication date: September 05, 2017.

Receive News & Ratings Via Email - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings with our FREE daily email newsletter.